STAC3
Basic information
Region (hg38): 12:57243453-57251188
Links
Phenotypes
GenCC
Source:
- Bailey-Bloch congenital myopathy (Strong), mode of inheritance: AR
- Bailey-Bloch congenital myopathy (Supportive), mode of inheritance: AR
- Bailey-Bloch congenital myopathy (Moderate), mode of inheritance: AR
- Bailey-Bloch congenital myopathy (Definitive), mode of inheritance: AR
- Bailey-Bloch congenital myopathy (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Congenital myopathy 13 | AR | Musculoskeletal; Pharmacogenomic | Among other findings, individuals have been described with susceptibility to malignant hyperthermia related to anesthesia, and awareness may allow preventive measures | Craniofacial; Musculoskeletal | 23736855 |
ClinVar
This is a list of variants' phenotypes submitted to
- Bailey-Bloch congenital myopathy (7 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STAC3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 41 | 43 | ||||
missense | 94 | 99 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 8 | |||||
inframe indel | 7 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 7 | 12 | 2 | 21 | ||
non coding | 51 | 11 | 68 | |||
Total | 8 | 5 | 112 | 95 | 13 |
Highest pathogenic variant AF is 0.0000263
Variants in STAC3
This is a list of pathogenic ClinVar variants found in the STAC3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-57243810-G-A | not specified | Benign (Mar 28, 2021) | ||
12-57243817-T-A | Bailey-Bloch congenital myopathy • Inborn genetic diseases | Uncertain significance (Jun 12, 2023) | ||
12-57243821-C-T | not specified • Bailey-Bloch congenital myopathy | Benign/Likely benign (Jan 18, 2024) | ||
12-57243825-A-G | Inborn genetic diseases | Uncertain significance (Aug 21, 2023) | ||
12-57243831-T-C | Inborn genetic diseases | Uncertain significance (Aug 02, 2021) | ||
12-57243834-G-A | Bailey-Bloch congenital myopathy | Uncertain significance (Jan 24, 2021) | ||
12-57243839-A-G | Bailey-Bloch congenital myopathy | Likely benign (Apr 12, 2022) | ||
12-57243855-C-A | Bailey-Bloch congenital myopathy • Inborn genetic diseases | Uncertain significance (Sep 17, 2023) | ||
12-57243878-G-A | Bailey-Bloch congenital myopathy | Likely benign (May 16, 2023) | ||
12-57243884-C-G | not specified • Bailey-Bloch congenital myopathy • STAC3-related disorder | Benign/Likely benign (Jul 01, 2024) | ||
12-57243884-C-T | Bailey-Bloch congenital myopathy | Likely benign (Jun 20, 2023) | ||
12-57243885-G-A | Bailey-Bloch congenital myopathy • Inborn genetic diseases | Uncertain significance (Jan 13, 2023) | ||
12-57243893-T-C | Bailey-Bloch congenital myopathy | Likely benign (Feb 26, 2019) | ||
12-57243899-C-G | Bailey-Bloch congenital myopathy | Uncertain significance (Mar 18, 2022) | ||
12-57243907-C-G | Inborn genetic diseases | Uncertain significance (Jul 14, 2023) | ||
12-57243908-G-C | Bailey-Bloch congenital myopathy | Uncertain significance (Apr 09, 2021) | ||
12-57243911-C-A | Bailey-Bloch congenital myopathy | Pathogenic (Jul 16, 2024) | ||
12-57243911-C-G | Bailey-Bloch congenital myopathy | Uncertain significance (Jul 14, 2021) | ||
12-57243912-TAGA-T | Bailey-Bloch congenital myopathy | Likely benign (Feb 21, 2023) | ||
12-57243916-A-C | Bailey-Bloch congenital myopathy | Likely benign (Aug 23, 2022) | ||
12-57243919-T-A | Bailey-Bloch congenital myopathy • STAC3-related disorder | Likely benign (Nov 29, 2023) | ||
12-57243934-T-C | Benign (Apr 05, 2021) | |||
12-57243967-ACAG-A | Likely benign (Mar 29, 2021) | |||
12-57244071-T-A | not specified • Bailey-Bloch congenital myopathy | Benign/Likely benign (Jan 31, 2024) | ||
12-57244084-C-T | Bailey-Bloch congenital myopathy | Uncertain significance (Aug 02, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STAC3 | protein_coding | protein_coding | ENST00000332782 | 11 | 7741 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000172 | 0.994 | 125693 | 0 | 55 | 125748 | 0.000219 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.906 | 180 | 218 | 0.827 | 0.0000122 | 2405 |
Missense in Polyphen | 76 | 84.692 | 0.89737 | 892 | ||
Synonymous | 1.26 | 62 | 75.9 | 0.817 | 0.00000398 | 652 |
Loss of Function | 2.44 | 10 | 22.5 | 0.445 | 0.00000122 | 256 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000814 | 0.000810 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000329 | 0.000326 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000230 | 0.000229 |
Middle Eastern | 0.000329 | 0.000326 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Required for normal excitation-contraction coupling in skeletal muscle and for normal muscle contraction in response to membrane depolarization. Required for normal Ca(2+) release from the sarcplasmic reticulum, which ultimately leads to muscle contraction. Probably functions via its effects on muscle calcium channels (PubMed:23736855, PubMed:29078335). Increases CACNA1S channel activity, in addition to its role in enhancing the expression of CACNA1S at the cell membrane. Has a redundant role in promoting the expression of the calcium channel CACNA1S at the cell membrane (By similarity). Slows down the inactivation rate of the calcium channel CACNA1C (PubMed:29078335). {ECO:0000250|UniProtKB:Q8BZ71, ECO:0000269|PubMed:23736855, ECO:0000269|PubMed:29078335}.;
- Disease
- DISEASE: Native American myopathy (NAM) [MIM:255995]: A disease characterized by congenital weakness and arthrogryposis, cleft palate, ptosis, short stature, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia provoked by anesthesia. {ECO:0000269|PubMed:23736855, ECO:0000269|PubMed:29078335}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.420
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.57
Haploinsufficiency Scores
- pHI
- 0.162
- hipred
- Y
- hipred_score
- 0.524
- ghis
- 0.571
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.758
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stac3
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; muscle phenotype;
Zebrafish Information Network
- Gene name
- stac3
- Affected structure
- fast muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- process quality
Gene ontology
- Biological process
- skeletal muscle contraction;neuromuscular synaptic transmission;intracellular signal transduction;skeletal muscle fiber development;positive regulation of voltage-gated calcium channel activity;positive regulation of protein localization to plasma membrane
- Cellular component
- nucleoplasm;cytosol;voltage-gated calcium channel complex;extrinsic component of cytoplasmic side of plasma membrane;sarcolemma
- Molecular function
- protein binding;identical protein binding;metal ion binding